Unknown

Dataset Information

0

Ibrutinib (imbruvica): a novel targeted therapy for chronic lymphocytic leukemia.

ABSTRACT: Ibrutinib (Imbruvica): a novel targeted therapy for chronic lymphocytic leukemia.

SUBMITTER: Parmar S 

PROVIDER: S-EPMC4103574 | biostudies-other | 2014 Jul

REPOSITORIES: biostudies-other

Json Xml
altmetric image

Publications

Ibrutinib (imbruvica): a novel targeted therapy for chronic lymphocytic leukemia.

Parmar Sapna S   Patel Khilna K   Pinilla-Ibarz Javier J  

P & T : a peer-reviewed journal for formulary management 20140701 7

Ibrutinib (Imbruvica): a novel targeted therapy for chronic lymphocytic leukemia. ...[more]